Despite a scarcity, several independent American pharmacies have ignored Ozempic shortages. (Photo : JOEL SAGET/AFP via Getty Images)This photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication "Ozempic" (semaglutide) made by Danish pharmaceutical company "Novo Nordisk".
The House Oversight Committee has launched an investigation into pharmacy benefit managers' tactics that Chairman James Comer (R-KY) said are "harming patient care and increasing costs for consumers." Comer is calling on senior officials at the Office of Personnel Management (OPM), Centers for Medicare and Medicaid Services and the Defense Health Agency (DHA) for documents and